Personalis, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Personalis, Inc. (PSNL) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.78 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-04
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 16.78M shares, a 16.43% increase year-over-year.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.06M shares, a 27.42% increase year-over-year.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 14.06M shares, a 43.34% increase year-over-year.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 14.41M shares, a 22.38% decline year-over-year.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 13.45M shares, a 44.38% increase from fiscal 2024.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.31M shares, a 44.54% decline from fiscal 2023.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 16.79M shares, a 84.10% increase from fiscal 2022.
- Personalis, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.12M shares, a 26.85% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 16.78M shares 10-Q · filed 2026-08-04 | 16.78M shares 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | 17.06M shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 13.45M shares 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 14.06M shares 10-Q · filed 2025-11-04 | 14.06M shares 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | 14.41M shares 10-Q · filed 2026-08-04 | 14.41M shares 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | 13.39M shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 9.31M shares 10-K · filed 2026-02-26 | |||
| 2024-09-30 | 9.81M shares 10-Q · filed 2025-11-04 | 9.81M shares 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | 18.57M shares 10-Q · filed 2025-08-05 | 18.57M shares 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | 18.89M shares 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | 16.79M shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 9.76M shares 10-Q · filed 2024-11-06 | 9.76M shares 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | 9.91M shares 10-Q · filed 2024-08-07 | 9.91M shares 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | 10.43M shares 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | 9.12M shares 10-K · filed 2024-02-28 | |||
| 2022-09-30 | 8.85M shares 10-Q · filed 2023-11-07 | 8.85M shares 10-Q · filed 2023-11-07 | ||
| 2022-06-30 | 6.73M shares 10-Q · filed 2023-08-08 | 6.73M shares 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | 6.87M shares 10-Q · filed 2023-05-03 | |||
| 2021-12-31 | 7.19M shares 10-K · filed 2024-02-28 | |||
| 2021-09-30 | 6.53M shares 10-Q · filed 2022-11-02 | 6.53M shares 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | 6.70M shares 10-Q · filed 2022-08-03 | 6.70M shares 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | 6.00M shares 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | 6.05M shares 10-K · filed 2023-02-23 | |||
| 2020-09-30 | 6.08M shares 10-Q · filed 2021-11-04 | 6.08M shares 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | 6.48M shares 10-Q · filed 2021-08-04 | 6.48M shares 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | 6.06M shares 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | 5.05M shares 10-K · filed 2022-02-24 | |||
| 2019-09-30 | 4.86M shares 10-Q · filed 2020-11-05 | 4.86M shares 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 4.75M shares 10-Q · filed 2020-08-06 | 4.75M shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 23.20M shares 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 22.86M shares 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 22.14M shares 10-Q · filed 2019-11-13 | 22.14M shares 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | 22.12M shares 10-Q · filed 2019-08-13 | 22.12M shares 10-Q · filed 2019-08-13 | ||
| 2017-12-31 | 21.55M shares 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |